| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Director
3 companies
Pratik S Multani is Chief Medical Officer at ORIC and has filed Form 4s across 3 companies. Pratik S Multani's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $750K at current prices.
Historically, Pratik S Multani's trades have earned a below-average insider score of 32/100 across 5 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -40.3%.
The biggest single holding is ORIC (~$654K) as Chief Medical Officer. The ORIC filings lean toward selling, a net 26,941 shares.
Pratik S Multani has 22 Form 4 filings on record from January 2015 to June 2026, across 3 companies: Director at Erasca (ERAS), 2021–2026; Chief Medical Officer at Oric Pharmaceuticals (ORIC), 2020–2026; Chief Medical Officer at Fate Therapeutics (FATE), 2015.
The 38 reported transactions were 23 option or other derivative awards, 4 option exercises, 4 open-market sales and 3 dispositions back to the company, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $99K and 4 sales worth about $223K.
The only open-market purchase was 6,200 shares of ERAS at an average $16.00 on July 20, 2021, about $99K. Twelve months later ERAS was down 59%.
The largest open-market sale was 10,720 shares of ORIC at an average $9.06 on December 16, 2025, about $97K.
None of the 3 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | ORIC Oric Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 10,720 | $9.06 | $97,128.56 | -13.6% | +34.0% | - | |
| Dec 16, 2024 | ORIC Oric Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 8,850 | $8.28 | $73,293.05 | -15.9% | -4.0% | +10.7% | |
| Dec 15, 2023 | ORIC Oric Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 5,282 | $8.59 | $45,350.72 | -18.2% | +61.3% | -8.5% | |
| Dec 15, 2022 | ORIC Oric Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 2,089 | $3.25 | $6,789.25 | -22.0% | +33.2% | +186.5% | |
| Jul 20, 2021 | ERAS Erasca, Inc. | Director | Buy | 6,200 | $16.00 | $99,200.00 | +3.7% | -11.7% | -59.0% |